FindTrial
Sign In

No

No

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-002213-19-SE
Enrollment
Unknown
Registered
2013-06-24
Start date
2013-09-13
Completion date
Unknown
Last updated
2013-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Amimox Pharmaceutical Form: Coated tablet Pharmaceutical form of the placebo: Tablet Route of administration of the placebo: Oral use Pharmaceutical form of the placebo: Tablet Route of ad

Sponsors

Malmö Högskola, Odontologiska fakulteten
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: No Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 1000 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 1000

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Main Objective: No;Secondary Objective: No;Primary end point(s): No;Timepoint(s) of evaluation of this end point: No—

Secondary

MeasureTime frame
Secondary end point(s): No;Timepoint(s) of evaluation of this end point: No—

Countries

Sweden

Contacts

Public ContactBengt Gotrick

Malmö Högskola, Odontologiska fakulteten

bengt.gotrick@mah.se+46406658427

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026